for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

JP Business

AstraZeneca sees COVID boost waning

AstraZeneca forecast higher 2022 sales and raised its annual dividend for the first time in a decade on Thursday, but warned that the boost from COVID-19 products would fall. Francis Maguire reports.

JP Business

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up